FIGURE

Figure 3

ID

ZDB-FIG-211029-129

Publication

Robinson et al., 2021 - A Novel Calpain Inhibitor Compound Has Protective Effects on a Zebrafish Model of Spinocerebellar Ataxia Type 3

Other Figures

All Figure Page

Back to All Figure Page

Figure 3

Delayed treatment with BLD-2736 or calpeptin produced a therapeutic benefit, despite administration after the onset of disease pathology. (A) Timeline displaying the onset of disease pathology at 2 dpf, treatment administration at 4 dpf, and examination of treatment efficacy at 6 dpf. (B) Treatment of SCA3 zebrafish from 4 to 6 dpf improved the distance swum when compared to vehicle treated SCA3 zebrafish. Swimming analysis was performed on n = 12–25 larvae per group. (C) Post-symptomatic treatment with calpain inhibitors produced a detectable decrease in the presence of detergent-insoluble EGFP-fused ataxin-3 particles. Each data point represents an experimental replicate, where n = 12–20 larvae were pooled together. All data are presented as mean ± SEM. * represents p < 0.05, ** represents p < 0.01, **** represents p < 0.0001.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cells